REXULTI
REXULTI
Approved
DIN Number
02461773
Drug Class
Human
Market Date
Apr 19, 2017
Company
HC
OTSUKA PHARMACEUTICAL CO., LTD.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02461773
AIG Number0158850004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX16 BREXPIPRAZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
BREXPIPRAZOLEActive
Strength: 2 MG
Monograph: BREXPIPRAZOLE